Tennessee · 114 session · senate
SB 2499TennCare - As introduced, requires a managed care organization or pharmacy benefits manager that is contracted with the bureau to reimburse a claim for a long-acting injectable drug intended for treatment and prevention of human immunodeficiency virus and administered in a pharmacy, physician's office, clinic, ambulatory surgical treatment center, or hospital. - Amends TCA Title 4; Title 56 and Title 71.
- Status
- Signed into law
- Latest action
- — Assigned to General Subcommittee of Senate Commerce and Labor Committee
- Primary sponsor
- Kyle
- TennCare
Sponsors
- Kyle · primaryprimary
Effective dates
What law changes on each date. Different sections can land on different dates.
- July 1, 2026In effect1 section
Extracted from the latest version's text.